Skip to main content

United States News All stories

Every story in this section, newest first — page 282 of 373.

Grafa

GATX toasts "exceptional year" with Q4 earnings beat and revenue surge

GATX (NYSE:GATX), the Chicago-based leader in railcar leasing, reported fourth-quarter adjusted earnings on Thursday that surpassed Wall Street expectations, capping an "exceptional year" marked by the completion of the largest acquisition in the company’s 127-year history.

Read more: GATX toasts "exceptional year" with Q4 earnings beat and revenue surge
Grafa
Insurance

Donegal annual profit surges as underwriting discipline offsets premium attrition

Donegal Group (NASDAQ:DGICA), the Marietta, Pennsylvania-based property and casualty insurer, reported fourth-quarter results that showcased a significant year-over-year jump in annual profitability, even as strategic non-renewals in its personal lines segment led to a dip in quarterly premiums.

Read more: Donegal annual profit surges as underwriting discipline offsets premium attrition
Grafa
Technology

Pool Corp. misses Q4 estimates as revenue declines, issues flat 2026 guidance

Covington, Louisiana-based Pool Corp. (NASDAQ:POOL), the world's largest wholesale distributor of swimming pool supplies and related equipment, posted fourth-quarter net income of $31.6 million, or 85 cents per share, for the period ended December 2025.

Read more: Pool Corp. misses Q4 estimates as revenue declines, issues flat 2026 guidance
Grafa
Tourism

Choice Hotels Posts Record Adjusted EBITDA of $625.6M in 2025

Choice Hotels International (NYSE:CHH) reported record adjusted EBITDA for full-year 2025 while delivering strong net income and franchise development momentum, as the lodging franchisor continued to benefit from international expansion and a robust pipeline despite softer domestic system growth.

Read more: Choice Hotels Posts Record Adjusted EBITDA of $625.6M in 2025
Grafa
Energy

CenterPoint misses Q4 profit estimates, but revenue beats on strong utility demand

CenterPoint Energy (NYSE:CNP) reported fourth-quarter results on Thursday that narrowly missed analyst expectations for earnings but highlighted an unprecedented acceleration in energy demand across the Greater Houston area.

Read more: CenterPoint misses Q4 profit estimates, but revenue beats on strong utility demand
Grafa
Health

Merck’s Enflonsia shows strong shield for high-risk kids in second RSV season

Merck (NYSE:MRK) released new data today demonstrating that its recently approved monoclonal antibody, Enflonsia (clesrovimab), remains safe and effective for high-risk children entering their second respiratory syncytial virus (RSV) season.

Read more: Merck’s Enflonsia shows strong shield for high-risk kids in second RSV season